| Application No | Product No | Proprietary Name | Active Ingredient | Dosage Form;Route | Strength | Company | Approval Date | RLD | Marketing Status | TE Code |
|---|---|---|---|---|---|---|---|---|---|---|
| (ANDA) 215328 | 001 | BUDESONIDE | BUDESONIDE | AEROSOL, FOAM;RECTAL | 2MG/ACTUATION | PADAGIS ISRAEL | 2023-04-12 | No | RX | AB |
| (ANDA) 215838 | 001 | CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | 0.05% | ALEMBIC | 2022-04-21 | No | RX | AB1 |
| (ANDA) 210809 | 001 | CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | 0.05% | GLENMARK PHARMS LTD | 2019-02-15 | No | RX | AB1 |
| (ANDA) 211450 | 001 | CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | 0.05% | GLENMARK PHARMS LTD | 2019-09-09 | No | RX | AB2 |
| (ANDA) 206805 | 001 | CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | 0.05% | NOVAST LABS | 2017-07-31 | No | DISCN | |
| (ANDA) 077763 | 001 | CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | 0.05% | PADAGIS ISRAEL | 2008-03-10 | No | RX | AB1 |
| (ANDA) 201402 | 001 | CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | 0.05% | PADAGIS ISRAEL | 2012-08-14 | No | RX | AB2 |
| (ANDA) 208779 | 001 | CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | 0.05% | TARO | 2018-10-04 | No | RX | AB1 |
| (ANDA) 091550 | 001 | KETOCONAZOLE | KETOCONAZOLE | AEROSOL, FOAM;TOPICAL | 2% | PADAGIS ISRAEL | 2011-08-25 | No | RX | AB |
| (ANDA) 210004 | 001 | CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | AEROSOL, FOAM;TOPICAL | 1% | TARO | 2020-03-11 | No | RX | AT |
| (ANDA) 090785 | 001 | CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | AEROSOL, FOAM;TOPICAL | 1% | PADAGIS ISRAEL | 2010-03-31 | No | RX | AT |
| (ANDA) 210778 | 001 | CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | AEROSOL, FOAM;TOPICAL | 1% | GLENMARK PHARMS LTD | 2021-09-20 | No | RX | AT |
| (ANDA) 215266 | 001 | HALOBETASOL PROPIONATE | HALOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | 0.05% | PADAGIS ISRAEL | 2023-08-11 | No | RX | AB |
| (ANDA) 078907 | 006 | FENTANYL CITRATE | FENTANYL CITRATE | TROCHE/LOZENGE;TRANSMUCOSAL | EQ 1.6MG BASE | SPECGX LLC | 2009-10-30 | No | DISCN | |
| (ANDA) 210928 | 001 | AZELAIC ACID | AZELAIC ACID | AEROSOL, FOAM;TOPICAL | 15% | TEVA PHARMS USA | 2020-10-07 | No | DISCN | |
| (ANDA) 207144 | 001 | BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | AEROSOL, FOAM;TOPICAL | 0.12% | NOVAST LABS | 2017-05-24 | No | DISCN | |
| (ANDA) 078337 | 001 | BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | AEROSOL, FOAM;TOPICAL | 0.12% | PADAGIS ISRAEL | 2012-11-26 | No | RX | AB |
| (ANDA) 208204 | 001 | BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | AEROSOL, FOAM;TOPICAL | 0.12% | TARO | 2017-05-24 | No | RX | AB |
| (ANDA) 210639 | 001 | BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | AEROSOL, FOAM;TOPICAL | 0.12% | XIROMED | 2023-04-18 | No | RX | AB |
| (ANDA) 214688 | 001 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE | AEROSOL, FOAM;TOPICAL | 0.064%;0.005% | GLENMARK PHARMS LTD | 2023-03-21 | No | RX | AB |